SGLT2 inhibitor treatment is not associated with an increased risk of osteoporotic fractures when compared to GLP-1 receptor agonists: A nationwide cohort study

BACKGROUND: Type 2 diabetes mellitus (T2D) is associated with an increased fracture risk. It is debated whether sodium-glucose cotransporter 2 (SGLT2) inhibitors influence fracture risk in T2D. We aimed to investigate the risk of major osteoporotic fractures (MOF) with SGLT2 inhibitors compared to g...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Mashhadi, Zheer Kejlberg, Viggers, Rikke, Starup-Linde, Jakob, Vestergaard, Peter, Gregersen, Søren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437938/
https://www.ncbi.nlm.nih.gov/pubmed/36060970
http://dx.doi.org/10.3389/fendo.2022.861422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437938/
https://www.ncbi.nlm.nih.gov/pubmed/36060970
http://dx.doi.org/10.3389/fendo.2022.861422

Ejemplares similares